Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06279065

Investigation of the Influence of the Human Microbiome on Giant Cell Arteritis

Investigation of the Influence of the Human Microbiome on the Pathogenesis and Recurrence Probability in Giant Cell Arteritis

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
University of Bonn · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The longitudinal observational study aims to assess the impact of the microbiome especially the gut-microbiome in the emergence and course of giant cell arteritis (abbr. GCA) patients. At diagnosis and 6 month follow up we will analyze the oral, blood and gut microbiome from GCA patients and healthy controls. Thereby identified potential candidate biota will be further analyzed for possible interactions and influence on the immune system.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAnalysis of blood and microbiome samples (stool, oral lavage)Analysis of blood and microbiome samples (stool, oral lavage) especially composition of the gut microbiome and potential interaction with immune cells

Timeline

Start date
2024-02-29
Primary completion
2026-02-18
Completion
2028-02-01
First posted
2024-02-26
Last updated
2024-05-09

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT06279065. Inclusion in this directory is not an endorsement.

Investigation of the Influence of the Human Microbiome on Giant Cell Arteritis (NCT06279065) · Clinical Trials Directory